Cannabis Health’s Post

A new era for chronic pain treatment? German pharma company Vertanical is on track to launch VER-01, the first whole-plant cannabis medicine with international approval. After 7 years and $250M invested, VER-01 has passed its Phase 3 trial in Germany, showing real promise for patients with chronic back pain, with mild initial side-effects, no addiction risk, and a non-opioid alternative to traditional pain relief. With Germany approval expected in 2026, Vertanical plans to expand across Europe and is also exploring the UK and US markets. Could this be a major step in changing clinicians’ long-held stigma around multi-compound cannabis medicines? 🌱 The future of pain management might just be multi-compound.